The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BrUOG360: A phase Ib/II study of copanlisib combined with rucaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
 
Benedito A. Carneiro
Consulting or Advisory Role - EMD Serono; Foundation Medicine; G1 therapeutics; Tempus
Research Funding - Abbvie (Inst); Actuate Therapeutics (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Pfizer (Inst); Repare Therapeutics (Inst); Repare Therapeutics (Inst)
 
Andre DeSouza
No Relationships to Disclose
 
Dragan Golijanin
No Relationships to Disclose
 
Roxanne Wood
No Relationships to Disclose
 
Adam J Olszewski
Research Funding - Adaptive Biotechnologies; Celldex (Inst); Genentech/Roche (Inst); Precision Biosciences (Inst); Spectrum Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Sheldon L. Holder
Employment - Access Care App; Hope Healthcare; Hope Healthcare (I)
Research Funding - Lilly
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Chimerix; Oncoceutics; p53-Therapeutics
Research Funding - D&D Pharmatech
Patents, Royalties, Other Intellectual Property - Patent on TIC10 (ONC201); Patents pending on the use of small molecules to target mutant p53
Other Relationship - Caris Life Sciences
 
Rahul Raj Aggarwal
Honoraria - Clovis Oncology
Consulting or Advisory Role - Advanced Accelerator Applications; AstraZeneca; Axiom Biotechnologies; Clovis Oncology; Dendreon
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); BioXCel therapeutics (Inst); Cancer Targeted Technology (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst); Xynomic Pharma (Inst); Zenith Epigenetics (Inst)
 
Anthony E. Mega
Honoraria - Astellas Pharma
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Astellas Medivation; Bristol-Myers Squibb